Andrew Ip, MD, MS, discusses the utility of investigational treatments for COVID-19 in patients with cancer.
Andrew Ip, MD, MS
Advertisement
Articles by Andrew Ip, MD, MS
Andrew Ip, MD, MS, discusses remaining questions with the COVID-19 vaccine in patients with cancer.
Andrew Ip, MD, MS, discusses the challenges of treating patients with hematologic malignancies and COVID-19.
Advertisement
Latest Updated Articles
Dr. Ip on the Utility of Investigational Treatments for COVID-19 in OncologyPublished: March 31st 2021 | Updated:
Dr. Ip on Remaining Questions With the COVID-19 Vaccine in OncologyPublished: March 23rd 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Unpacking the FDA Approvals That Reshaped Cancer Care in 2025
2
Relacorilant Plus Nab-Paclitaxel Meets OS End Point of ROSELLA Trial in PROC
3
GDF-15 Blockade May Deepen Neoadjuvant IO Response in Cisplatin-Ineligible MIBC
4
ILUSTRO Trial Signals Role for First-Line Zolbetuximab-Based Triplet for Biomarker-Selected Gastric Cancer
5